Anne Moore

Dr. Anne Moore

School of Biochemistry and Cell Biology, University College Cork, Cork, T12 XF62, reland
orcid

Research Focus & Metrics

Academic Career Length

33Years (1994-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 November 2007 in JAMA
Verified
Journal Article
Open access
PDF file
CBCaryn Bern
Caryn Bern
SMSusan P. Montgomery
Susan P. Montgomery
BHBarbara L. Herwaldt
Barbara L. Herwaldt
ARAnis Rassi
Anis Rassi
JMJose Antonio Marin-Neto
Jose Antonio Marin-Neto
AMAnne Moore
Anne Moore
Quiz Ref ID Chagas disease is caused by Trypanosoma cruzi, a protozoan parasite usually transmitted by infected triatomine bugs. Transmission also occurs through transfusion or organ transplantation, from mother to infant, and rarely by ingestion of contaminated food or drink.1-3 Vector-borne transmission occurs exclusively in the Americas, where an estimated 8 million to 10 million people have Chagas disease.4,5 Historically, transmission has occurred predominantly in rural areas of Latin America, where poor housing conditions have promoted contact with infected vectors. Successful programs to reduce vector- and blood-borne transmission, as well as migration within and beyond endemic countries, have changed the epidemiology of the disease.4,6,7

16 September 2008 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
NSNathan W. Schmidt
Nathan W. Schmidt
RPRebecca L. Podyminogin
Rebecca L. Podyminogin
NBNoah S. Butler
Noah S. Butler
VBVladimir P. Badovinac
Vladimir P. Badovinac
BTBrad J. Tucker
Brad J. Tucker
JHJohn T. Harty
John T. Harty
Infection of mice with sporozoites of Plasmodium berghei or Plasmodium yoelii has been used extensively to evaluate liver-stage protection by candidate preerythrocytic malaria vaccines. Unfortunately, repeated success of such vaccines in mice has not translated readily to effective malaria vaccines in humans. Thus, mice may be used better as models to dissect basic parameters required for immunity to Plasmodium -infection than as preclinical vaccine models. In turn, this basic information may aid in the rational design of malaria vaccines. Here, we describe a model of circumsporozoite-specific memory CD8 T cell generation that protects mice against multiple P. berghei sporozoite challenges for at least 19 months. Using this model we defined a threshold frequency of memory CD8 T cells in the blood that predicts long-term sterilizing immunity against liver-stage infection. Importantly, the number of Plasmodium -specific memory CD8 T cells required for immunity greatly exceeds the number required for resistance to other pathogens. In addition, this model allowed us to identify readily individual immunized mice that exceed or fall below the protective threshold before infection, information that should greatly facilitate studies to dissect basic mechanisms of protective CD8 T cell memory against liver-stage Plasmodium infection. Furthermore, the extremely large threshold in memory CD8 T cell frequencies required for long-term protection in mice may have important implications for development of effective malaria vaccines.

1 April 2012 in Journal of Controlled Release
Verified
Journal Article
Closed access
AVAnto Vrdoljak
Anto Vrdoljak
MMMarie G. McGrath
Marie G. McGrath
JCJohn B. Carey
John B. Carey
SDSimon Draper
Simon Draper
AHAdrian V.S. Hill
Adrian V.S. Hill
AMAnne Moore
Anne Moore

1 March 2000 in Journal of Clinical Microbiology
Verified
Journal Article
Closed access
PDF file
UMUna Morgan
Una Morgan
RWRainer Weber
Rainer Weber
LXLihua Xiao
Lihua Xiao
ISIrshad Sulaiman
Irshad Sulaiman
RTR. C. Andrew Thompson
R. C. Andrew Thompson
PDPeter Deplazes
Peter Deplazes
A total of 22 Cryptosporidium isolates from human immunodeficiency virus-infected patients from Kenya, Switzerland, and the United States were examined at three genetic loci: the 18S ribosomal DNA, HSP-70, and acetyl coenzyme A synthetase genes. Four distinct Cryptosporidium genotypes were identified: (i) the Cryptosporidium parvum “human” genotype, (ii) the C. parvum “cattle” genotype, (iii) Cryptosporidium felis , and (iv) Cryptosporidium meleagridis . This is the first report of C. meleagridis in a human host. These results and those of others indicate that immunocompromised individuals are susceptible to a wide range of Cryptosporidium species and genotypes. Future studies are required to understand the full public health significance of Cryptosporidium genotypes and species in immunocompromised hosts.

1 August 2011 in International Journal of Pharmaceutics
Verified
Journal Article
Closed access
MMMarie G. McGrath
Marie G. McGrath
AVAnto Vrdoljak
Anto Vrdoljak
Conor O'mahonyConor O'mahony
Conor O'mahony
JOJorge C. Oliveira
Jorge C. Oliveira
AMAnne Moore
Anne Moore
ACAbina Crean
Abina Crean

27 July 2008 in Nature Medicine
Verified
Journal Article
Closed access
PDF file
SDSimon Draper
Simon Draper
AMAnne Moore
Anne Moore
AGAnna L Goodman
Anna L Goodman
CLCarole A Long
Carole A Long
AHAnthony A Holder
Anthony A Holder
AHAdrian V S Hill
Adrian V S Hill